Kayne Anderson Rudnick Investment Management LLC Neurocrine Biosciences Inc Transaction History

Kayne Anderson Rudnick Investment Management LLC

  • $39.8 Billion
  • Q2 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$75.79 - $100.07 $3,789 - $5,003
-50 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$72.45 - $94.81 $3,550 - $4,645
49 Added 4900.0%
50 $5,000
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $79 - $106
1 New
1 $0
Q1 2021

May 17, 2021
SELL
$87.57 - $119.4 $1,138 - $1,552
-13 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$86.91 - $108.33 $1,129 - $1,408
13 New
13 $1,000

Others Institutions Holding NBIX

# of Institutions
683
Shares Held
102M
Call Options Held
290K
Put Options Held
214K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email